Aggregation-induced emission material as well as preparation method and application thereof
Through the development of aggregation-induced luminescent materials and smartphone detection programs, the rapid detection and effective inhibition problems in the diagnosis and treatment of fungal infections are solved, and the rapid judgment and light treatment of Candida albicans are achieved, simplifying the diagnosis and treatment of fungal infections are carried out. The process has the potential of smart home health testing equipment.
Patent Information
- Application Number
- CN202310610042.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-25
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art is difficult to quickly and effectively diagnose and deal with fungal infections, especially in the case of tight medical resources. Traditional in vitro detection methods take a long time and are cumbersome to operate, and fungal infections are difficult to cure and are prone to drug resistance.
Aggregation-induced luminescence material was developed, prepared by Suzukii coupling reaction and nitrile reagent reaction, combined with a smartphone detection program, for the preparation of antibacterial medical dressings and liquid auxiliary materials, and the use of fluorescence changes to achieve rapid judgment of fungal infection and light treatment.
It has achieved rapid detection and effective inhibition of Candida albicans, has the potential for photodynamic treatment, simplified the diagnosis and treatment process of fungal infection, and has great potential as a smart home health testing device.
Smart Images

Figure BDA0004252222350000021 
Figure BDA0004252222350000025 
Figure BDA0004252222350000031
Abstract
Description
Technical Field
[0001] The present invention relates to the field of aggregation-induced luminescence materials, and in particular to an aggregation-induced luminescence material, a preparation method thereof, and application thereof in wound detection. Background Art
[0002] Microbial drug-resistant infections have become a global public health problem. Compared with Gram-negative and Gram-positive bacteria, fungi have a hard cell wall composed of glycoproteins and polysaccharide polymers, which creates a strong barrier to drug penetration. Therefore, fungal infections are difficult to cure and prone to drug resistance, and early detection and intervention are necessary. The current in vitro method for clinical diagnosis is usually sampling and culture, which takes 1-3 days and is cumbersome to operate. Although early warning and diagnosis of fungal infections are crucial, the number of patients willing to undergo clinical testing is limited. Especially in the context of tight medical resources and infectious disease outbreaks, hospital fungal infection testing is more inconvenient for patients, especially those with chronic infections and postoperative trauma treatment.
[0003] Based on this, a new solution is needed. Summary of the invention
[0004] The technical solution adopted by the present invention to solve the technical problem is to provide an aggregation-induced luminescence material, wherein the aggregation-induced luminescence material has the following structure:
[0005]
[0006] Wherein, E is selected from one of O, S and Se, and R1 is selected from One of the following, R2 is R3 is
[0007] The present invention also provides a method for preparing the aggregation-induced emission material as described above, characterized in that it comprises the following steps:
[0008] Compound a is reacted with a boronic acid having an R1 substituent through a Suzukii coupling reaction to obtain compound b;
[0009] Compound b is reacted with a boronic acid having an R2 substituent through a Suzukii coupling reaction to obtain compound c;
[0010] Compound c is reacted with a nitrile reagent having an R3 substituent to obtain a crude product, which is then separated by column chromatography to obtain the aggregation-induced emission material;
[0011] The structural formulas of compounds a, b and c are as follows:
[0012]
[0013]
[0014] E is selected from one of O, S and Se, R1 is selected from One of the following, R2 is R3 is
[0015] The present invention also provides a use of the aggregation-induced luminescence material as described above in the preparation of a medical dressing for photodynamic therapy.
[0016] The present invention also provides a use of the aggregation-induced luminescence material as described above in the preparation of a liquid auxiliary material for fungal infection detection and treatment.
[0017] In the application provided by the present invention, the fungus is Candida albicans.
[0018] The present invention also provides an aggregation-induced luminescence wound liquid dressing, which comprises raw materials in the following mass ratios: 60%-75% of acrylic copolymer, 5%-15% of polyurethane, 5%-10% of glycerol, 10-15% of deionized water and 2%-10% of the aggregation-induced luminescence material as described in claim 1.
[0019] In the aggregation-induced luminescence wound liquid dressing provided by the present invention, the aggregation-induced luminescence wound liquid dressing comprises raw materials in the following mass ratio: 68% acrylic copolymer, 10% polyurethane, 8% glycerol, 10% deionized water and 4% of the aggregation-induced luminescence material as described in claim 1.
[0020] The present invention also provides a system for detecting and treating fungal wound infections, comprising the aggregation-induced luminescence wound liquid dressing as described above and a smartphone detection program.
[0021] The implementation of the present invention can achieve the following beneficial effects:
[0022] The present invention proposes a new aggregation-induced luminescence material, which has a good effect of generating reactive oxygen in vitro, and thus has good photodynamic therapy potential; the aggregation-induced luminescence wound dressing prepared using the aggregation-induced luminescence material has strong antibacterial activity against Candida albicans, indicating that it has potential use in preparing medical dressings for photodynamic therapy; based on this, the present invention also develops a new intelligent infected wound detection and treatment system based on the above-mentioned aggregation-induced luminescence material, including the above-mentioned aggregation-induced luminescence wound liquid dressing and a mobile phone application. When in use, the fluorescence change of the aggregation-induced luminescence material is used as a detection standard. Through the mobile phone application, the fluorescence change of the aggregation-induced luminescence wound liquid dressing after contacting the fungus Candida albicans can be identified, thereby achieving rapid judgment of Candida albicans infection and performing light therapy, thereby having great potential as a smart home health detection device. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below. Obviously, the drawings in the following description are only embodiments of the present invention. For those of ordinary skill in the art, other drawings can be obtained based on the provided drawings without creative work:
[0024] Figure 1 Shown is the synthesis route of the aggregation-induced emission material provided by the present invention;
[0025] Figure 2 The figure shows the active oxygen generation diagram of the present invention; wherein the left figure is the active oxygen diagram under different pH environments, and the right figure is the active oxygen diagram under different aggregation degrees;
[0026] Figure 3 Shown are diagrams showing the antibacterial effects of the dressing of the present invention under different conditions;
[0027] Figure 4 The figure shows the detection process of the intelligent infection wound detection and treatment system of the aggregation-induced luminescence material of the present invention;
[0028] Figure 5 Shown are the treatment and effect diagrams of the intelligent infection wound detection and treatment system of the aggregation-induced luminescence material of the present invention. DETAILED DESCRIPTION
[0029] In order to have a clearer understanding of the technical features, purposes and effects of the present invention, the specific embodiments of the present invention are now described in detail with reference to the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments described in this specification, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0030] The present invention has developed a new intelligent infected wound detection and treatment system based on aggregation-induced luminescence material, and based on this system has developed an aggregation-induced luminescence material wound liquid dressing. It is found for the first time that this wound liquid dressing has significant inhibitory activity against Candida albicans and has the potential to be used as an effective medical dressing for photodynamic therapy.
[0031] Based on this, the present invention provides an aggregation-induced luminescence material, wherein the aggregation-induced luminescence material has a structure as shown below:
[0032]
[0033] Wherein, E is selected from one of O, S and Se, and R1 is selected from One of the following, R2 is R3 is
[0034] At the same time, a method for preparing the above-mentioned aggregation-induced emission material is also provided, comprising the following steps:
[0035] Compound a is reacted with a boronic acid having an R1 substituent through a Suzukii coupling reaction to obtain compound b;
[0036] Compound b is reacted with a boronic acid having an R2 substituent through a Suzukii coupling reaction to obtain compound c;
[0037] Compound c is reacted with a nitrile reagent having an R3 substituent to obtain a crude product, which is then separated by column chromatography to obtain the aggregation-induced emission material;
[0038] The structural formulas of compounds a, b and c are as follows:
[0039]
[0040] E is selected from one of O, S and Se, R1 is selected from One of the following, R2 is R3 is
[0041] Furthermore, the prepared compound is loaded in a liquid dressing to obtain a novel liquid wound dressing material with a photodynamic therapy effect. The aggregation-induced luminescence wound liquid dressing comprises the following raw materials in a mass ratio: 60%-75% acrylic copolymer, 5%-15% polyurethane, 5%-10% glycerol, 10-15% deionized water and 2%-10% of the aggregation-induced luminescence material as described above. Based on the above-mentioned aggregation-induced luminescence wound liquid dressing of the present invention, its liquid form is easy to be used as a medical dressing, and it is easy to form a film to facilitate wound treatment. Therefore, it is a matrix with great potential for the development of wound dressings.
[0042] Furthermore, the present invention uses an in vitro antibacterial activity test to evaluate the antibacterial activity of the above compounds. The results show that the aggregation-induced luminescence wound liquid auxiliary material has obvious inhibitory activity against Candida albicans, and has great potential as an antibacterial medical dressing for photodynamic therapy. The application of this type of wound liquid dressing as an antibacterial medical dressing has significant inhibitory activity against Candida albicans.
[0043] Furthermore, the present invention has also developed a new intelligent infected wound detection and treatment system based on the above-mentioned aggregation-induced luminescent material, including the above-mentioned aggregation-induced luminescent wound liquid dressing and a mobile phone application. When in use, the fluorescence change of the aggregation-induced luminescent material is used as the detection standard. Through the mobile phone application, the fluorescence change of the aggregation-induced luminescent wound liquid dressing after contacting the fungus Candida albicans can be identified, thereby achieving rapid judgment of Candida albicans infection and performing light treatment. Therefore, it has great potential as a smart home health detection device.
[0044] Example 1 Preparation of Aggregation-Induced Emission Materials
[0045] The synthetic route of the above-mentioned aggregation-induced emission materials is as follows Figure 1As shown. Compound a (9mmol), boronic acid with different substituents R1 (9mmol), potassium carbonate (36mmol) and tetrakistriphenylphosphine palladium (0.34mmol) were added to a 1000mL double-necked round-bottom flask, and 250mL of distilled toluene and 80mL of water were added. The mixture was then heated to reflux for 8h under nitrogen, cooled to room temperature, poured into water, and extracted three times with dichloromethane. The organic phase was washed with a saturated sodium chloride solution and dried over anhydrous magnesium sulfate. After filtration and solvent evaporation, compound b was purified by silica gel column chromatography, and compound c was obtained by the above steps. Sodium hydride (4mmol) was dissolved in a dry N,N-dimethylformamide solution, added to the raw material containing the R3 substituent (2mmol) at 0°C and reacted for 30min, then carbon disulfide (8mmol) was added and reacted at room temperature for 2h. Compound c (0.4mmol) was dissolved in dry N,N-dimethylformamide and placed in the mixture. The mixture was stirred at 80°C overnight. After cooling to room temperature, the mixture was poured into water and extracted three times with dichloromethane. The organic phase was washed with a saturated sodium chloride solution and dried over anhydrous magnesium sulfate. After filtration and solvent evaporation, it was purified by silica gel column chromatography to obtain compound d.
[0046] The following are the names, numbers, physical states, and NMR data of the aggregation-induced emission materials synthesized using the above method.
[0047] Compound d: yield 40%, solid powder. 1 H NMR (400MHz, CDCl3): δ8.78 (d, 2H, J = 4.52Hz), 7.93-7.80 (m, 4H), 7.79-7.76 (m, 2H), 7.63 -7.58(m,2H),7.38-7.33(m,5H),7.28-7.26(m,3H),7.25-7.20(m,2H),7.16-7.11(m,4H). 13 C NMR (100MHz, CDCl3): δ153.1,146.9,146.8,146.7,146.6,130.6,130.4,130.3,130.2,130.0,129.9,129.8,129.7,129.6, 129.5,128.0,126.0,125.9,125.8,125.7,124.5,124.4,124.3,124.1,122.5,122.3,121.1,120.9,77.3,77.2,77.0,76.7.
[0048] Example 2 Preparation of Aggregation-Induced Luminescence Wound Liquid Dressing
[0049] 68% acrylic copolymer, 10% polyurethane, 8% glycerol, and 10% deionized water were added to a round-bottom flask, mechanically stirred for 24 hours, and then placed in a UV sterilizer for 30 minutes. 4% aggregation-induced luminescence material was added to the sterilized liquid, stirred at room temperature, and an aggregation-induced luminescence wound liquid dressing was obtained, and a film-forming property test was performed.
[0050] Example 3 Antibacterial activity of aggregation-induced luminescence wound liquid dressing
[0051] 1. Test bacteria:
[0052] Candida albicans (C.albicans).
[0053] 2. Sample preparation:
[0054] Accurately weigh a certain amount of the test compound into a centrifuge tube, add 1 mL of sterile water to make a 2 μmol / L solution, and use 0.9% NaCl as a blank control.
[0055] 3. Preparation of solid culture medium:
[0056] 7.5g tryptone, 2.5g soy peptone, 2.5g NaCl, 7.5g agar powder, add 500ml deionized water, and adjust the pH to 5.5.
[0057] 4. Determination of antibacterial activity:
[0058] Antibacterial activity was measured by plate colony counting method. Aggregation-induced luminescence wound dressing was added to 10 9 CPU / mL bacterial solution was mixed and irradiated under white light (5mW / cm 2 ) for 1 minute and placed in a 37°C constant temperature and humidity incubator for incubation. Each treatment was repeated three times. After incubation for 16 hours, the number of colonies was counted and the antibacterial rate of each test compound was calculated according to the following formula.
[0059]
[0060] C is the colony count of the experimental group; C0 is the colony count of the blank control group.
[0061] The test results can be found in Figure 2 to Figure 4 , that is, the inhibitory activity of the aggregation-induced luminescence wound dressing on C.albicans (2 μM). The results show that under light stimulation, at a concentration of 2 μM, the aggregation-induced luminescence wound dressing exhibits a certain inhibitory activity on Candida albicans. It can be seen that the aggregation-induced luminescence wound liquid dressing involved in the present invention has a strong antibacterial activity against Candida albicans and has a potential use for preparing medical dressings for photodynamic therapy.
[0062] Specifically, Figure 2 The results showed that the material had a good effect in generating reactive oxygen species in vitro. Both the results of total reactive oxygen species generation and singlet oxygen showed that the material had good photodynamic therapy potential. Figure 3 The results showed that after 1 minute of low-power white light irradiation, the material showed a significant inhibitory effect on Porphyromonas gingivalis, with an inhibition rate of more than 96%. The intelligent infection wound detection and treatment system developed by aggregation-induced luminescence material was used to detect and treat mouse infection. Figure 4 , Figure 5 The display system is sensitive in responding to infection detection and has excellent treatment effects.
[0063] The embodiments of the present invention are described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific embodiments. The above-mentioned specific embodiments are merely illustrative and not restrictive. Under the guidance of the present invention, ordinary technicians in this field can make many modifications without departing from the scope of protection of the present invention and the claims, all of which belong to the scope of protection of the present invention.
Claims
1. An aggregation-induced emission material, characterized in that: The aggregation-induced emission material has the following structure: Wherein, E is selected from one of O, S and Se, and R1 is selected from One of the following, R2 is R3 is 2. A method for preparing the aggregation-induced emission material according to claim 1, characterized in that: The following steps are involved: Compound a is reacted with a boronic acid having an R1 substituent through a Suzukii coupling reaction to obtain compound b; Compound b is reacted with a boronic acid having an R2 substituent through a Suzukii coupling reaction to obtain compound c; Compound c is reacted with a nitrile reagent having an R3 substituent to obtain a crude product, which is then separated by column chromatography to obtain the aggregation-induced emission material; The structural formulas of compounds a, b and c are as follows: E is selected from one of O, S and Se, R1 is selected from One of the following, R2 is R3 is 3. Use of the aggregation-induced emission material as claimed in claim 1 in the preparation of a medical dressing for photodynamic therapy.
4. Use of the aggregation-induced luminescence material according to claim 1 in the preparation of a liquid auxiliary material for fungal infection detection and treatment.
5. The use according to claim 3, characterized in that The fungus is Candida albicans.
6. An aggregation-induced luminescence wound liquid dressing, characterized in that: The aggregation-induced luminescence wound liquid dressing comprises the following raw materials in the following mass ratios: 60%-75% acrylic copolymer, 5%-15% polyurethane, 5%-10% glycerol, 10-15% deionized water and 2%-10% of the aggregation-induced luminescence material according to claim 1.
7. The aggregation-induced luminescence wound liquid dressing according to claim 6, characterized in that: The aggregation-induced luminescence wound liquid dressing comprises raw materials in the following mass ratios: 68% acrylic copolymer, 10% polyurethane, 8% glycerol, 10% deionized water and 4% of the aggregation-induced luminescence material as claimed in claim 1.
8. A system for detecting and treating fungal wound infections, characterized in that: It comprises the aggregation-induced luminescence wound liquid dressing as described in claim 6 and a smart phone detection program.
